
CAS 1130067-34-3
:Formel:C26H28N4O2
InChl:InChI=1S/C26H28N4O2/c31-24(22-11-10-20-6-4-5-7-21(20)18-22)27-14-17-29-15-12-26(13-16-29)25(32)28-19-30(26)23-8-2-1-3-9-23/h1-11,18H,12-17,19H2,(H,27,31)(H,28,32)
InChI Key:FAIFAFUXFFWVNQ-UHFFFAOYSA-N
SMILES:C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCNC(=O)C4=CC5=CC=CC=C5C=C4
Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 Produkte gefunden.
N-[2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)ethyl]-2-naphthalenecarboxamide
CAS:Formel:C26H28N4O2Reinheit:95%Farbe und Form:SolidMolekulargewicht:428.5261N-(2-(4-Oxo-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-8-Yl)Ethyl)-2-Naphthamide
CAS:N-(2-(4-Oxo-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-8-Yl)Ethyl)-2-NaphthamideFormel:C26H28N4O2Reinheit:98+%Molekulargewicht:428.53CAY10594
CAS:CAY10594, a PLD2 inhibitor, mitigates acetaminophen liver damage via the p-GSK-3β/JNK pathway.Formel:C26H28N4O2Reinheit:97.76%Farbe und Form:White SolidMolekulargewicht:428.53CAY10594
CAS:CAY10594 is a small molecule that inhibits the activity of MMP-9 and blocks the inflammatory response in bowel disease. In vitro studies have shown that CAY10594 inhibits protein synthesis by blocking cation channels and reduces inflammation in an animal model. This drug has also been shown to inhibit the proliferation of cancer cells, including breast cancer cells, by blocking epidermal growth factor receptors. The effects of CAY10594 are mediated through its interaction with basic fibroblast growth factor, fatty acid binding protein, and epidermal growth factor receptor.
Formel:C26H28N4O2Reinheit:Min. 95%Molekulargewicht:428.53 g/mol





